ClinConnect ClinConnect Logo
Search / Trial NCT06275191

Alternatives to Dental Opioid Prescribing After Tooth Extraction

Launched by DOUGLAS OYLER · Feb 16, 2024

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

Although use of nonsteroidal antiinflammatory drugs and acetaminophen is recommended first-line by the American Dental Association and American Association of Oral and Maxillofacial Surgeons, dentists and oral surgeons are leading prescribers of opioids to adolescents and young adults (AYA), who are at high risk for developing problematic opioid use after an initial exposure. This multi-site, stepped wedge cluster-randomized trial will assess whether a multicomponent behavioral intervention can influence opioid prescribing behavior among dentists and oral surgeons compared to usual practice...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria (Provider):
  • Actively U.S. licensed dentist or oral surgeon practicing at a participating cluster. Participating clinics were finalized prior to the beginning of the study based on the following criteria: (1) perform tooth extractions on at least 70 AYA patients during a 5-month screening period from July 1, 2022 through November 30, 2022 and (2) electronically prescribe opioids to at least 30% of AYA patients who underwent extraction during the screening period. Additionally, each participating cluster signed a data use agreement (DUA) for sharing electronic health record data, can provide the necessary electronic health record data, and agreed to comply with study procedures and be available for the duration of the study.
  • Provide a signed and dated informed consent form.
  • Willing to comply with all study procedures and be available for the duration of the study.
  • Inclusion Criteria (Patient):
  • Undergoes any tooth extraction at a participating cluster during the study (intervention condition, transition period, or control condition) between 6-10 days earlier.
  • Age 12-25 at the time of tooth extraction.
  • Reads and acknowledges survey cover letter in lieu of a full consent/assent process.
  • Can access the electronic survey using an internet-capable device.
  • Exclusion Criteria:
  • There are no other exclusion criteria for clusters or provider/patient participants that meet all inclusion criteria.

About Douglas Oyler

Douglas Oyler is a dedicated clinical trial sponsor with a commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and treatments, the organization collaborates with leading research institutions and healthcare professionals to conduct rigorous clinical trials across various therapeutic areas. Douglas Oyler emphasizes ethical practices, patient safety, and scientific integrity, ensuring that every study is designed to generate meaningful data that contributes to the development of effective healthcare solutions. Through its strategic partnerships and expert team, Douglas Oyler aims to drive breakthroughs that enhance the quality of life for patients worldwide.

Locations

Lexington, Kentucky, United States

Patients applied

0 patients applied

Trial Officials

Douglas R Oyler, PharmD

Principal Investigator

University of Kentucky

Marcia V Rojas Ramirez, DDS

Principal Investigator

University of Kentucky

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported